Corporate Corruption News Articles
Excerpts of Key Corporate Corruption News Articles in Major Media


Below are many highly revealing one-paragraph excerpts of important corporate corruption articles from the mainstream media. Links are provided to the full articles on major media websites. If any link should fail to function, click here. These corporate corruption news articles are listed by order of importance. For the same articles by date posted to this list, click here. For the list by date of news article click here. By choosing to educate ourselves on these important issues and to spread the word, we can and will build a brighter future.



Note: For an index to revealing excerpts of media articles on several dozen engaging topics, click here.

Texas Governor Defends Vaccine Order
2007-02-22, MSNBC/Associated Press
http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=AP&Date=2...

Gov. Rick Perry on Thursday angrily defended his relationship with Merck & Co. and his executive order requiring that schoolgirls receive the drugmaker's vaccine against the sexually transmitted cervical-cancer virus. The Associated Press reported Wednesday that Perry's chief of staff had met with key aides about the vaccine on Oct. 16, the same day Merck's political action committee donated $5,000 to the governor's campaign. In issuing the order, the governor made Texas the first state to require the vaccine Gardasil for all schoolgirls. But many lawmakers have complained about his bypassing the Legislature altogether. The executive order has inflamed conservatives, who said it contradicts Texas' abstinence-only sexual education policies and intrudes into families' lives. Critics have previously questioned Perry's ties to Merck. Mike Toomey, Perry's former chief of staff, now lobbies for the drug company. And the governor accepted a total of $6,000 from Merck during his re-election campaign. Merck has waged a behind-the-scenes lobbying campaign to get state legislatures to require girls to get the three-dose vaccine to enroll in school. But on Tuesday the pharmaceutical company announced it was suspending the effort because of pressure from parents and medical groups. The Kentucky House on Thurday passed a bill that would require the vaccination for middle school girls unless their parents sign a form opposing it. Virginia lawmakers have also passed legislation requiring the vaccine, but the governor has not decided if he will sign it.

Note: The drug company lobby is the most powerful in the U.S., as reported by the former editor-in-chief of one of the most respected medical journals in the U.S. Click here for more.




ExxonMobil tried to mislead, scientists say
2007-01-04, Boston Globe/Associated Press
http://www.boston.com/business/globe/articles/2007/01/04/exxonmobil_tried_to_...

ExxonMobil Corp. gave $16 million to 43 ideological groups between 1998 and 2005 in an effort to mislead the public by discrediting the science behind global warming, the Union of Concerned Scientists asserted yesterday. The report by the advocacy group mirrors similar claims by Britain's leading scientific academy. Last September, The Royal Society wrote the oil company asking it to halt support for groups that "misrepresented the science of climate change." Alden Meyer, the Union of Concerned Scientists' strategy and policy director, said in a teleconference that ExxonMobil based its tactics on those of tobacco companies, spreading uncertainty by misrepresenting peer-reviewed scientific studies or emphasizing only selected facts. James McCarthy, a professor at Harvard University, said the company has sought to "create the illusion of a vigorous debate" about global warming.




Science a la Joe Camel
2006-11-26, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2006/11/24/AR20061124007...

At hundreds of screenings this year of "An Inconvenient Truth," the first thing many viewers said after the lights came up was that every student in every school in the United States needed to see this movie. The producers of former vice president Al Gore's film about global warming ... certainly agreed. So the company that made the documentary decided to offer 50,000 free DVDs to the National Science Teachers Association (NSTA). It seemed like a no-brainer. In their e-mail rejection, they expressed concern that ... they didn't want to offer "political" endorsement of the film; and they saw "little, if any, benefit to NSTA or its members" in accepting the free DVDs. As for classroom benefits, the movie has been enthusiastically endorsed by leading climate scientists worldwide, and is required viewing for all students in Norway and Sweden. But there was one more curious argument in the e-mail: Accepting the DVDs, they wrote, would place "unnecessary risk upon the [NSTA] capital campaign, especially certain targeted supporters." One of those supporters, it turns out, is the Exxon Mobil Corp. That's the same Exxon Mobil that for more than a decade has done everything possible to muddle public understanding of global warming and stifle any serious effort to solve it. It has run ads in leading newspapers ... questioning the role of manmade emissions in global warming, and financed the work of a small band of scientific skeptics who have tried to challenge the consensus that heat-trapping pollution is drastically altering our atmosphere. NSTA says it has received $6 million from the company since 1996. Exxon Mobil has a representative on the group's corporate advisory board.




Fuelling debate
2006-07-10, Toronto Star
http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Articl...

A poignant new documentary asks who killed GM's promising electric car project? A new documentary released June 28 in New York and Los Angeles, appropriately titled Who Killed The Electric Car? tries in Clue-like fashion to figure out why GM pulled the plug on its EV1 electric vehicle program, which by most accounts was approaching success when the first prototype was introduced in the mid-1990s. "It was a revolutionary, modern car, requiring no gas, no oil changes, no mufflers, and rare brake maintenance," according to a synopsis of the film. In the 1990s a strict clean-air mandate introduced in California that called for zero-emission vehicles was what led GM to introduce the EV1. Eventually that California mandate got watered down from "zero" to "low" emissions, and the automakers decided to literally blow up their EV programs. GM, which leased out the EV1 cars it produced, called them all back after California changed its policy. The cars were crushed and shredded. Who were the people leasing these vehicles? Tom Hanks, Mel Gibson and Ted Danson, among others, many of whom appear in the movie and talk favourably about their electric cars. If the implications of an advance means loss of future business to a paradigm, the key players of that paradigm will lobby to kill it. The paradigm? Big oil. Similarly, the auto industry has an interest in perpetuating the manufacture of vehicles that require routine, costly maintenance.

Note: For more information and showing times on the highly revealing Who Killed The Electric Car, visit www.whokilledtheelectriccar.com. For even deeper information www.WantToKnow.info/newenergysources




Exposed: the secret corporate funding behind health research
2006-02-07, The Guardian (One of the UK's leading newspapers)
http://www.guardian.co.uk/comment/story/0,,1703694,00.html

Academics and the media have failed dismally to ask the crucial question of scientists' claims: who is paying you? In the 1990s...[Arise] was one of the world's most influential public-health groups. It described itself as "a worldwide association of eminent scientists who act as independent commentators". Its purpose...was to show how "everyday pleasures, such as eating chocolate, smoking, drinking tea, coffee and alcohol, contribute to the quality of life". "Scientific studies show that enjoying the simple pleasures in life, without feeling guilty, can reduce stress and increase resistance to disease". Between September 1993 and March 1994,...[Arise] generated 195 newspaper articles and radio and television interviews, in places such as the Wall Street Journal, the International Herald Tribune, the Independent, the Evening Standard, El País, La Repubblica, Rai and the BBC. In 1998...[tobacco] firms were obliged to place their internal documents in a public archive. Among them...is a memo from...Philip Morris - the world's largest tobacco company. The title is "Arise 1994-95 Activities and Funding". This showed that in the previous financial year Arise had received $373,400: ...over 99% - from Philip Morris, British American Tobacco, RJ Reynolds and Rothmans. The memo suggests Arise was run not by eminent scientists but by eminent tobacco companies. How much more science is being published in academic journals with undeclared interests like these? How many more media campaigns...have been secretly funded and steered by corporations?

Note: If you want to understand how corporate interests secretly manipulate both scientific results and public perception, this excellent article is well worth reading.




DuPont Stuck With Big Teflon Fine
2005-12-14, CBS/Associated Press
http://www.cbsnews.com/stories/2005/12/14/business/main1124537.shtml

DuPont Co. has agreed to pay $10.25 million in fines and $6.25 million for environmental projects in a settlement with the Environmental Protection Agency over the company's alleged failure to report the dangers of a toxic chemical used to make Teflon. EPA officials said the settlement represents the largest civil administrative penalty the agency has ever obtained under any federal environmental statute. The EPA alleged that DuPont withheld information for more than 20 years about the health effects of PFOA. DuPont faced a potential fine of more than $300 million for not reporting that the chemical posed a substantial risk of injury to health or the environment. "The settlement allows us to put this matter behind us and move forward," said [DuPont general counsel Stacey] Mobley, who noted that the company has cut PFOA emissions from U.S. plant sites by 98 percent and hopes to reduce emissions even further by 2007. DuPont...still faces a federal criminal investigation of its actions concerning PFOA. In a draft report released in June, the majority of members on a scientific advisory board that reviewed the EPA's draft risk assessment concluded that the chemical is "likely" to be carcinogenic to humans.




Gulf Between Top, Bottom Gets Wider
2005-05-31, Los Angeles Times
http://www.latimes.com/business/careers/work/la-fi-execpay31may31,1,7406992.s...

A Times survey of the state's largest companies shows that CEOs' pay is growing at a much faster pace than that of rank-and-file employees. The difference is even sharper at the top rungs of the ladder. The 10 highest-paid executives on this year's list earned 36.7% more than last year's top 10 — garnering a collective $467.5 million. That's enough to buy about 275 homes in Malibu or 1.5 million sets of golf clubs or two 747 jumbo jets. Although limited to California companies, the survey reflects a national trend: a widening chasm between the pay of chief executives and rank-and-file employees. CEOs at California's largest 100 public companies took home a collective $1.1 billion in 2004, up almost 20% from 2003. That compares with the 2.9% raise that the average California worker saw last year. The average CEO made 42 times the average worker's pay in 1980. That increased to 85 times in 1990 and is now over 300 times. Sometimes, executive pay soars even in bad years. Sanmina-SCI Corp., a San Jose telecommunications company with $12 billion in sales, lost money in 2003 and 2004. Yet Chief Executive Jure Sola scored a 1,500% hike in total pay during 2004, according to The Times survey. Sola was paid $19.8 million last year, while the company lost $14.9 million.




Merck CEO Resigns as Drug Probe Continues
2005-05-06, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2005/05/05/AR20050505011...

Merck & Co.'s longtime leader Raymond V. Gilmartin abruptly resigned yesterday on the same day congressional investigators released a slew of documents detailing how the company continued to aggressively promote its arthritis drug Vioxx after it knew of potentially serious safety concerns. The documents...showed that Merck directed its 3,000-person Vioxx sales force to avoid discussions with doctors about the cardiovascular risks identified in a major clinical trial of the drug in 2000. Sales representatives were told instead to rely on a "Cardiovascular Card" that said Vioxx was protecting the heart rather than potentially harming it. They were [also] trained how to smile, speak and position themselves most effectively when talking with doctors, and were exhorted to sell Vioxx and other Merck drugs using the Rev. Martin Luther King Jr.'s "I Have a Dream" speech. Vioxx was withdrawn from the market last September after another clinical trial found that people who had taken the drug for 18 months were five times more likely to have heart attacks and strokes than those on a placebo. Merck was sharply criticized in a hearing into how the company and the Food and Drug Administration had handled the safety concerns surrounding Vioxx.




EPA Mercury Rule Omits Conflicting Data
2005-03-22, Washington Post
http://www.washingtonpost.com/wp-dyn/articles/A55268-2005Mar21.html

When the Environmental Protection Agency unveiled a rule last week to limit mercury emissions from U.S. power plants, officials emphasized that the controls could not be more aggressive because the cost to industry already far exceeded the public health payoff. What they did not reveal is that a Harvard University study paid for by the EPA, co-authored by an EPA scientist and peer-reviewed by two other EPA scientists had reached the opposite conclusion. That analysis estimated health benefits 100 times as great as the EPA did, but top agency officials ordered the finding stripped from public documents.




Sex Crimes Cover-Up By Vatican?
2003-08-06, CBS News
http://www.cbsnews.com/stories/2003/08/06/eveningnews/main566978.shtml

For decades, priests in this country abused children in parish after parish while their superiors covered it all up. Now it turns out the orders for this cover up were written in Rome at the highest levels of the Vatican. [A] confidential Vatican document, obtained by CBS News, lays out a church policy that calls for absolute secrecy when it comes to sexual abuse by priests – anyone who speaks out could be thrown out of the church. The policy was written in 1962 by Cardinal Alfredo Ottaviani. The document, once "stored in the secret archives" of the Vatican, focuses on crimes initiated as part of the confessional relationship. Bishops are instructed to pursue these cases "in the most secretive way ... restrained by a perpetual silence ... and everyone (including the alleged victim) ... is to observe the strictest secret, which is commonly regarded as a secret of the Holy Office ... under the penalty of excommunication." Larry Drivon, a lawyer who represents alleged victims, said, “This document is significant because it's a blueprint for deception. It's an instruction manual on how to deceive and how to protect pedophiles ... and exactly how to avoid the truth coming out." Richard Sipe, a former priest who has written about sex abuse and secrecy in the church, said the document sends a chilling message. “You keep it secret at all costs,” Sipe said. “It's happened in every diocese in this country.” According to church records, the document was a bedrock of Catholic sex abuse policy until America's bishops met last summer and drafted new policies to address the crisis in the church.




A Real Chip On Your Shoulder
2003-07-17, CBS News/Associated Press
http://www.cbsnews.com/stories/2003/07/17/tech/main563819.shtml

A U.S. company launched Thursday in Mexico the sale of microchips that can be implanted under a person's skin and used to confirm everything from health history to identity. The microchips ... went on sale last year in the United States. The microchip, the size of a grain of rice, is implanted in the arm or hip and can contain information on everything from a person's blood type to their name. In a two-hour presentation, Palm Beach, Florida-based Applied Digital Solutions Inc. introduced reporters to the VeriChip and used a syringe-like device and local anesthetic to implant a sample in the right arm of employee Carlos Altamirano. “It doesn't hurt at all,” he said. “The whole process is just painless.” Antonio Aceves, the director of the Mexican company charged with distributing the chip here, said that in the first year of sales, the company hoped to implant chips in 10,000 people and ensure that at least 70 percent of all hospitals had the technology to read the devices. One chip costs $150 and has a $50 annual fee. Users can update and manage their chips' information by calling a 24-hour customer service line. The VeriChip can track subjects who are within 5 miles, but officials want to develop a new chip that can use satellite technology to track people who are farther away and may have been kidnapped. While the idea of using the chip to track people has raised privacy concerns in the United States, the idea has been popular with Mexicans. The company hopes to have the new anti-kidnapping chip developed by 2003.




California medical schools earn A's in conflict grading
2008-06-04, San Francisco Chronicle (San Francisco's leading newspaper
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/06/04/BUV3112O9V.DTL

Drug companies shower medical school faculty members with pens, pricey dinners, free samples and other inducements to influence their prescribing patterns, an organization of U.S. medical students says. The med students are now trying to erase that pattern by grading their teachers. The American Medical Student Association issued its second annual report card ... on the conflict-of-interest policies maintained at 150 universities that grant a medical degree. California dominated the honor roll. UC Davis, UCSF and UCLA captured three of the seven A grades across the country. But only 15 percent of U.S. medical schools made the top of the class with a grade of A or B, based on their adoption of rules such as barring drug companies from distributing lavish gifts to physicians. Sixty of the schools, or 40 percent, got an F on the student association's 2008 PharmFree Scorecard. The American Medical Student Association started its PharmFree campaign in 2002 after members shared their concerns about interactions they observed between their medical professors and drug industry representatives. The Association of American Medical Colleges in April proposed that all med schools adopt policies to prevent drug marketing efforts from distorting the educational environment. The proposed rules would restrict industry funding of seminars, forbid companies from selecting the recipients of scholarships they fund and strongly discourage medical school faculty members from participating in industry-sponsored speakers' bureaus.

Note: For a treasure trove of important reports on health issues from reliable sources, click here.




Firms Seek Patents on 'Climate Ready' Altered Crops
2008-05-13, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2008/05/12/AR20080512029...

A handful of the world's largest agricultural biotechnology companies are seeking hundreds of patents on gene-altered crops designed to withstand drought and other environmental stresses, part of a race for dominance in the potentially lucrative market for crops that can handle global warming. Three companies -- BASF of Germany, Syngenta of Switzerland and Monsanto of St. Louis -- have filed applications to control nearly two-thirds of the climate-related gene families submitted to patent offices worldwide, according to the report by the Ottawa-based ETC Group, an activist organization that advocates for subsistence farmers. Many of the world's poorest countries, destined to be hit hardest by climate change, have rejected biotech crops, citing environmental and economic concerns. Importantly, gene patents generally preclude the age-old practice of saving seeds from a harvest for replanting, requiring instead that farmers purchase the high-tech seeds each year. The ETC report concludes that biotech giants are hoping to leverage climate change as a way to get into resistant markets, and it warns that the move could undermine public-sector plant-breeding institutions such as those coordinated by the United Nations and the World Bank, which have long made their improved varieties freely available. "When a market is dominated by a handful of large multinational companies, the research agenda gets biased toward proprietary products," said Hope Shand, ETC's research director. "Monopoly control of plant genes is a bad idea under any circumstance. During a global food crisis, it is unacceptable and has to be challenged."

Note: For many disturbing reports on risks from genetic engineering from major media sources, click here.




Bush administration rules limit lawsuits
2008-05-13, Boston Globe/Associated Press
http://www.boston.com/business/articles/2008/05/13/bush_administration_rules_...

Faced with an unfriendly Congress, the Bush administration has found another, quieter way to make it more difficult for consumers to sue businesses over faulty products. It's rewriting the bureaucratic rulebook. Lawsuit limits have been included in 51 rules proposed or adopted since 2005 by agency bureaucrats governing just about everything Americans use: drugs, cars, railroads, medical devices and food. Decried by consumer advocates and embraced by industry, the agencies' use of the government's rule-making authority represents the administration's final act in a long-standing drive to shield companies from lawsuits. Of the 51 regulations, 41 came from the Food and Drug Administration and the National Highway Traffic Safety Administration, or NHTSA. Underlying this bureaucratic version of lawsuit reform is the concept of federal preemption. Rooted in the Supremacy Clause of the Constitution, federal preemption refers to circumstances in which federal law and regulation trump state law, in this instance state laws that govern when one person may be held liable for another's injury. An expansive interpretation of preemption leaves little room for consumers to sue, and that is what the national trial lawyers group, the American Association for Justice, says is taking place. Jon Haber, AAJ's chief executive officer, says the agencies are engaging in "a brazen end run around Congress, the Constitution and the states in an effort to let negligent corporations off the hook and knowingly put consumers at risk."

Note: For lots more on government corruption from major media sources, click here.




Nanoparticles scrutinized for health effects
2008-05-12, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/05/12/BU4P10BB88.DTL

Windows cleaned by raindrops, white sofas immune to red wine spills, tiles protected from limescale buildup -- new products created from minute substances called nanoparticles are making such domestic dreams come true. Based on tiny particles 10,000 times thinner than a strand of hair, ... nanoparticles are showing up in everything from fabric coatings to socks to plush teddy bears. But some scientists are concerned that these seemingly magical materials are hitting the market before their effects on human health and the environment have been sufficiently studied. The few scientific reports available suggest that nanoparticles can pose a threat to human health and to the environment. For example, fish swimming in water containing modest amounts of fullerenes, soccer-ball-shaped nanoparticles made out of 60 carbon atoms, showed a large increase in brain damage. These are the same types of fullerenes being used in various skin products. From the skin, they can travel through the lymphatic duct system to lymph nodes and eventually end up in organs such as the liver, kidney and spleen. When inhaled, nanoparticles will go deeper into the lungs than larger particles and reach more sensitive parts. Because of that, scientists are particularly concerned about nanoparticles being used in spray products. "We have research showing that as a material shrinks in size, it becomes more harmful to the lungs. Nanoparticles tend to be more inflammatory to the lung, and it seems as if the lung has to work harder to get rid of them," said Andrew Maynard, chief science adviser at the Project on Emerging Nanotechnologies in Washington.

Note: For a treasure trove of health reports from major media, click here.




FDA warns Merck to fix vaccine plant problems
2008-04-30, San Francisco Chronicle/Associated Press
http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2008/04/30/financial/f084419...

The Food and Drug Administration has ordered Merck & Co. to correct numerous manufacturing deficiencies at its main vaccine plant. The agency ... released a warning letter sent to Merck's chief executive, Richard T. Clark, that states FDA inspectors determined manufacturing rules are not being followed at the plant in West Point, Pa., just outside Philadelphia. The plant, which recalled two vaccines in December over sterility problems, makes a number of children's vaccines and four for adults. The nine-page letter states FDA found "significant objectionable conditions" in the manufacture of vaccines and drug ingredients during repeated inspections from Nov. 26 to Jan. 17. According to the heavily redacted warning letter, Merck officials didn't thoroughly investigate when vaccine batches inexplicably failed to meet specifications, even if batches had been distributed, and some combination measles-mumps-rubella shots that failed "visual inspection for critical defects" were distributed anyway. Production of two vaccines made at West Point — PedvaxHIB, to prevent Haemophilus influenza type B, and Comvax, a combination vaccine for Haemophilus B and hepatitis B — stopped last year and 1.2 million doses of them were recalled after a sterility problem was discovered in October. The plant also makes ProQuad, which protects children against measles, mumps, rubella and chickenpox; hepatitis A, hepatitis B and meningitis vaccines for children and adults; and Gardasil, to protect young women against cervical cancer.

Note: For further revelations from reliable sources on the dangers of vaccines, click here.




A Bailout. For Everyone.
2008-03-12, Washington Post
http://www.washingtonpost.com/wp-dyn/content/story/2008/03/11/ST2008031103060...

Last week, it was a $200 billion cash-for-bond swap for the banks. This week, it was a $200 billion bond-for-bond swap for the big investment houses. If they keep this up, pretty soon you'll be able to walk into any Federal Reserve bank and hock that diamond brooch you inherited from Aunt Mildred. Forget all that nonsense about the Bernanke Fed being too timid or behind the curve. In the face of what is turning into the most serious financial market crisis since the Great Depression, the Fed has been more aggressive and more creative in using its limitless balance sheet -- in effect, its ability to print money -- than at any time in history. We can argue till the cows come home about whether this is a bailout for Wall Street. It is -- but only to the extent that it is also a bailout for all of us, meant to prevent a financial and economic meltdown that drags everyone down with it. In broad strokes, we're going through a massive "de-leveraging" of the economy, wringing out trillions of dollars of debt that had artificially driven up the price of real estate and financial assets, and, more generally, allowed Americans to live beyond their means. Fed officials warn that this de-leveraging is nowhere near finished. It's anyone's guess how long this credit crunch will last, but the chances are that we'll have several more market meltdowns and Fed rescues before it's over, probably in the fall. Until then, the dollar will continue to get hammered and stocks will continue their fitful decline. And if the last two financially induced recessions are any guide, it will be well into 2009 before the economy hits bottom, followed by a couple of years of slow growth and "jobless" recovery.

Note: The title of this article is quite revealing. A bailout for the big banks is considered to be a bailout for everyone. If you believe this, we most highly encourage you to read our powerful two-page summary of the banking cover-up available here.




FDA to Back Food From Cloned Animals
2008-01-05, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2008/01/04/AR20080104036...

The Food and Drug Administration is set to announce as early as next week that meat and milk from cloned farm animals and their offspring can start making their way toward supermarket shelves. The decision would be a notable act of defiance against Congress, which last month passed appropriations legislation recommending that any such approval be delayed pending further studies. Moreover, the Senate version of the Farm bill ... contains stronger, binding language that would block FDA action on cloned food, probably for years. The FDA has hinted strongly in the past year that it is ready to lift its "voluntary moratorium" on the marketing of milk and meat from clones and their offspring, saying that the science led them to that decision. But public opinion has been negative on the issue, with some saying that not enough safety studies have been conducted and others concerned about the health of the clones, which are far more likely than ordinary farm animals to die early in life. A handful of U.S. companies have pushed for marketing approval. Margaret Mellon of the Union of Concerned Scientists, an advocacy group, said she had read the entire 678-page draft risk assessment and found it to be "long on assumptions and short on data, and especially short on the data that are directly relevant to food consumption safety." Of particular concern, she said, was that even though the vast majority of clones die either before birth or soon after, those that survive are deemed normal. She said the FDA should withhold approval at least until it has a regulatory plan in place that will give it an ability to track food from clones and watch for human health impacts. Others have called for mandatory labeling so consumers can avoid products from clones. The FDA has said that lacking any safety concerns, it will not demand such labels. The Agriculture Department has also declared that meat from clones cannot be deemed organic.

Note: For lots more reliable information on how big business takes huge risks with the food we eat, click here.




Big Brother Spying on Americans' Internet Data?
2007-11-07, ABC News
http://abcnews.go.com/Politics/Story?id=3833172

According to a former AT&T employee, the government has warrantless access to a great deal of Internet traffic should they care to take a peek. As information is traded between users it flows also into a locked, secret room on the sixth floor of AT&T's San Francisco offices and other rooms around the country -- where the U.S. government can sift through and find the information it wants, former AT&T employee Mark Klein alleged Wednesday at a press conference on Capitol Hill. "An exact copy of all Internet traffic that flowed through critical AT&T cables -- e-mails, documents, pictures, Web browsing, voice-over-Internet phone conversations, everything -- was being diverted to equipment inside the secret room," he said. Klein ... said that as an AT&T technician overseeing Internet operations in San Francisco, he helped maintain optical splitters that diverted data en route to and from AT&T customers. One day he found that the splitters were hard-wired into a secret room on the sixth floor. Documents he obtained [from] AT&T showed that highly sophisticated data mining equipment was kept there. Conversations he had with other technicians and the AT&T documents led Klein to believe there are 15 to 20 such sites nationwide, including in Seattle, Los Angeles, San Jose, San Diego and Atlanta, he said. Brian Reid, a former Stanford electrical engineering professor who appeared with Klein, said the NSA would logically collect phone and Internet data simultaneously because of the way fiber optic cables are intertwined. He said ... the system described by Klein suggests a "wholesale, dragnet surveillance." Of the major telecom companies, only Qwest is known to have rejected government requests for access to data. Former Qwest CEO Joseph Nacchio, appealing an insider trading conviction last month, said the government was seeking access to data even before Sept. 11.




Panel: Kids Shouldn't Use Cold Medicines
2007-10-20, San Francisco Chronicle/Associated Press
http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2007/10/18/national/w000553D...

The medicines long used by parents to treat their children's coughs and colds don't work and shouldn't be used in those younger than 6, federal health advisers recommended. "The data that we have now is they don't seem to work," said Sean Hennessy, a University of Pennsylvania epidemiologist. The recommendation applies to medicines containing one or more of the following ingredients: decongestants, antihistamines and antitussives. In two separate votes ... the panelists said the medicines shouldn't be used in children younger than 2 or in those younger than 6. A third vote, to recommend against use in children 6 to 11, failed. The panel's advice dovetails with a petition filed by pediatricians that argued the over-the-counter medicines shouldn't be given to children younger than 6, an age group they called the most vulnerable to potential ill effects. The American Academy of Pediatrics and other groups back the petition. But FDA officials and panelists agreed there's no evidence they work in older children, either. Still, panelists held off from recommending against use in those 6 and older. And some said they feared such a prohibition wouldn't eliminate use of the medicines by parents. "They will administer adult products to their children because they work for them or feel they work for them," said the panel's patient and family representative, Amy Celento of Nutley, N.J. Some of the drugs — which include Wyeth's Dimetapp and Robitussin, Johnson & Johnson's Pediacare and Novartis AG's Triaminic products — have never been tested in children, something flagged as long ago as 1972 by a previous FDA panel. An FDA review found just 11 studies of children published over the last half-century. Those studies did not establish that the medicines worked in those cases, according to the agency.

Note: For a powerful exposé of corporate and government corruption in the health industry, click here.





Key Corporate Corruption News Articles in Major Media